Rohrau, Lower Austria, 2471 AustriaOur work reaches back to 1986. As part of the research facilities of the previous company Stauffer Chemicals, work originally focused on the development of maize herbicides. Our guiding principle of highest quality was established, remaining unchanged to the present day. An essential criterion generated at our trial sites for the establishment of our test facility in these days were representative soil and climate conditions for Central and Eastern Europe complemented by excellent infrastructure. Today, top quality and flexibility form the basis of our international success.

Leberstrasse 20/2, Vienna, 1110 AustriaOur Mission. … is to provide and to develop novel highly-innovative laboratory tests to identify (rare) diseases on an early stage to give patients the chance for a personalized therapeutical treatment with best possible outcome. Finding the correct diagnosis particularly for children and patients with rare disorders can take months or even years while disease has begun to progress… We commit to change this situation to make better laboratory tests accessible. Personalized Diagnostics for Better Health! We are pioneering new ways to provide better laboratory services to you!

20 Leberstraße, Wien, Wien 1110, ATOur Mission. … is to provide and to develop novel highly-innovative laboratory tests to identify (rare) diseases on an early stage to give patients the chance for a personalized therapeutical treatment with best possible outcome. Finding the correct diagnosis particularly for children and patients with rare disorders can take months or even years while disease has begun to progress… We commit to change this situation to make better laboratory tests accessible. Personalized Diagnostics for Better Health! We are pioneering new ways to provide better laboratory services to you!

Vienna, Vienna AustriaThe AIT Austrian Institute of Technology provides research and technological development to realize basic innovations for the next generation of infrastructure related technologies in the fields of health & environment, energy, mobility and safety & security.

Donau-City-Straße 1 Vienna, 1220 AustriaThe AIT Austrian Institute of Technology provides research and technological development to realize basic innovations for the next generation of infrastructure related technologies in the fields of health & environment, energy, mobility and safety & security.

A-8020 Graz, Austria, Reininghausstr. 49Aurora Fine Chemicals offers screening, target identification, profiling, and custom synthesis services.

Brehmstraße 14A Vienna, 1110 AustriaAttoquant Diagnostics provides LC-MS/MS based peptide quantification services at premium quality. We are specialized in the biochemical characterization of peptide hormone cascades with a major focus on the Renin-Angiotensin-Aldosterone-System. In addition to the quantification of different functionally related angiotensin metabolite panels (RAS-FingerprintTM), we offer highly sensitive activity assays for proteolytic enzymes that are based on natural peptide substrates. We also support you in bio-analytical planning, sample measurement and data interpretation. Attoquant Diagnostics provides MORE THAN JUST DATA!

25 Sankt-Peter-Straße Linz, Oberösterreich, 4020 AustriaSynlab Pharma offers method validation/development, physicochemical characterization, stability studies, impurity profiling, bioanalytics, PK/PD studies, clinical trial support, reference standards, and release analysis services.

7a Holunderstraße Hinterleiten, Niederösterreich, 3032 Austria

84 Hauptstraße Hinterleiten, Niederösterreich, 3032 Austria

BBMRI-ERIC Neue Stiftingtalstrasse 2/B/6 8010 Graz AUSTRIAEssential for the understanding of the diversity of human diseases, biological samples and corresponding data are required for the development of any new drug or diagnostic assay and are therefore critical for the advancement in health research, ultimately leading to personalised medicine. Biobanks also will provide key information on the influence of environment and lifestyle on health, constituting a basis for disease prevention programmes and the improvement of public health.

Vienna Competence Center Lazarettgasse 19 1090 Vienna AustriaBiomay offers recombinant proteins, plasmid DNA, and manufacturing services.

Schärdinger Str. 1, 4061 Pasching, AustriaOur laboratory in the central area of ​​Linz has worked with great success in the field of microbiological analysis of food and industrial hygiene since 1991. In April 2008 we received accreditation according to DIN EN ISO / IEC 17025, as amended, was first awarded by the Federal Ministry of Economics, Research and Youth. In order to meet the high quality requirements, we undergo continuous quality controls. Our qualified staff guarantees a quick processing of samples and the rapid transmission of test results. To make this possible, our team is also at the weekend for the samples further processing in use. Our laboratory is working with government-authorized appraisers in accordance with § 73 LMSVG together which are authorized at the customer to issue an internationally recognized findings.

Neue Stiftingtalstrasse 2, Eingang B, 2. Stock 8010 8010 Graz ÖsterreichThe biobank at the Medical University of Graz has a collection of biological samples with associated data in a structured usable form. With some six million biological samples, it counts as one of the biggest establishments of its kind in Europe. The aim of Biobank Graz is to contribute to better health care of the population.

P.O. Box 39, A-1150 Vienna, AustriaBiotechnology Consulting is a drug development and regulatory affairs management consultancy.

Am Kanal 27, 2nd Floor Vienna, Austria, 1110 AustriaAt bit.bio discovery, we combine industry-defining iPSC models with unbiased functional genomic CRISPR (knock-out/activation/interference) screening and single cell transcriptomic read-outs to query human biology at single cell resolution. Our technology platform has applications in drug target discovery and validation, drug mechanism of action studies, disease modelling, and variant-to-gene mapping.

Campus Vienna Biocenter 2 Vienna 1030 Vienna AustriaBender MedSystems offers assay development, custom antibodies, in vitro diagnostics, and ELISAs.

Wetzawinkel 20 A Hofstaetten an der Raab, Styria, 8200 Austria

14 Petersgasse Graz, Steiermark, 8010 Austria

2 Helmut-Qualtinger-Gasse Wien, Wien, 1030 Austriabiolution is an international scientific communications and consulting company at the Vienna BioCenter in Neu Marx specializing in the life sciences sector. While we work within a large network of collaborators with complementary expertise, our core services are performed exclusively by our highly experienced and well-trained full-time staff. In our experience this ensures our services not only a consistently high level of quality, but also allows the effective delegation of tasks to the appropriate team member. Our experienced team of life scientists from a wide variety of scientific backgrounds is complemented by a professional media design team. Based on this multidisciplinary expertise and more than a decade of science communication experience biolution has built a state-of the-art 3 D visualization pipeline to generate scientifically accurate 3D models for instructive visualizations and videos. Our services in brief: 3D VISUALIZATION (still & animated, Videos) Educational | teaching | marketing | information | broadcasting | documentary | fundraising | public relations | media relations | social media COMMUNICATION Corporate design | Web- & graphic design | Print material |Social media | Video recording | Text editing CONSULTING EU funded cooperation in H2020 | ERC | FET | SME calls | Marie Skłodowska-Curie | Eurostars | EMBO fellowship | FWF | WWTF | LBG Institutes PROJECT MANAGEMENT Communication | Project controlling | Legal/financial/administrative support | Corrective measures | Meetings organisation & moderation EVENTS Strategy & concept development | Advice & support with presentations | Moderation | Public funding and sponsoring | Event marketing | Public relations inquiries | Technical set up & implementation

Dr.-Bruno-Klein-Strasse 2 Woerdern, 3423 AustriaBiovest Consulting GmbH is an Austrian based life science and drug development consulting company established in 2002. Biovest primarily focusses on designing and managing rabbit monoclonal antibody development projects and acts as general contractor for its clients in pharmaceutical and biotech R&D departments. Biovest 's services are engaged for the scientific design and logistical management of challenging projects by a select group of clients.

Dr.-Bruno-Klein-Strasse 2 A-3423 Woerdern, AustriaBiovest Consulting GmbH is an Austrian based life science and drug development consulting company established in 2002. Biovest primarily focusses on designing and managing rabbit monoclonal antibody development projects and acts as general contractor for its clients in pharmaceutical and biotech R&D departments. Biovest 's services are engaged for the scientific design and logistical management of challenging projects by a select group of clients.

Eduard-Bodem-Gasse 8 Innsbruck , Tirol, 6020 AustriaA targeted metabolomics kits and services company that addresses the two main challenges in metabolomics, acquiring excellent, reproducible data and interpreting meaningful results. biocrates offers: - Broad, quantitative coverage of more than 1000 metabolites using LC-MS/MS approaches - High throughput, standardized methods that are scalable for longitudinal and large cohort studies - A highly applicable workflow for a wide range of species and samples (plasma, feces, tissue, etc.) with low sample volumes (as little as 10 uL for most biofluids) - The ability to adapt our methods to the needs of a specific project - Expert annotation of results and biological interpretation - Applications in a variety of diseases and systems with recent applications in nutrition and wellbeing, neurology, infectious disease, and the microbiome We offer a variety of assays, metabolomics kits, and services. - MxP Quant 500 Kit Assay: Comprehensive coverage of up to 107 small molecules/metabolites and 523 lipids from 26 different analyte classes (Applications: microbiome interactions, Alzheimer’s disease, aging, nutrition, etc.) - AbsoluteIDQ p180 Kit Assay: Coverage of up to 43 small molecules/metabolites and 145 lipids from 7 different analyte classes (Applications: Alzheimer’s disease, nutrition, aging, etc.) - AbsoluteIDQ Bile Acids Kit Assay: Coverage of up to 10 primary and 10 secondary bile acids (Applications: Alzheimer’s disease, Chron’s disease, fitness and wellbeing, non-alcoholic fatty liver disease, Parkinson’s, etc.) - AbsoluteIDQ Stero17 Kit Assay: Coverage of up to 17 steroid hormones from all five major classes (Applications: animal health, steroid disorders, etc.) - Lipid Assay: Coverage of up to 326 lipids from 10 different lipid classes (Applications: heart disease, diabetes, obesity, Alzheimer’s disease, lipid metabolism disorders, etc.) - Oxysterol Assay: Coverage of up to 18 free (oxy-) sterols (Applications: cholesterol disorders, Alzheimer’s disease, ALS, etc.) - Tryptophan Metabolism Assay: Coverage of up to 17 metabolites from the tryptophan pathway (Applications: aging, microbiome research, fitness, and wellbeing, etc.) - Acylcarnitine Assay: Coverage of up to 43 acylcarnitines + free carnitine (Applications: neurological disorders, aging, dementia, etc.) - SCFA+ Assay: Coverage of up to 11 short- and 8 medium-chain fatty acids, including 8 branched-chain fatty acids (Applications: Nutrition, inflammation, energy metabolism, insulin resistance, autoimmune diseases, gut microbiome, gut-brain axis, gut-immune axis, etc.) Data Analysis Services - Data interpretation and statistical analysis services: analysis literature search, pathway analysis and visualization, interpretation of univariate and multivariate statistics, PCA, ANOVA, PLS-DA, hierarchical cluster analysis, boxplots, and other data visualization upon request - MetaboINDICATOR analysis: over 230 biologically relevant metabolite sums and ratios to help draw biological conclusions from data

Campus Vienna Biocenter II Viehmarktgasse 2A Vienna, 1030 AustriaBiosynth is an innovative global life sciences reagents, custom synthesis, and manufacturing services company that secures the fragment pharma and diagnostic supply chain. With an unrivaled research product portfolio and end-to-end manufacturing services, Biosynth is science-led and customer-focused on solving problems and delivering key reagents at scale and with quality. Our expertise and capability runs across fine chemicals/small molecules, peptides and key biologics all from one trusted partner. We manufacture and source a vast range of chemical and biochemical products, and take pride in delivering products that others cannot. We provide a full range of products and services to support life science research and development, with more than a million products in our research catalog and many hundreds of complex manufacturing service projects. Our small molecule chemistry specialties include enzyme substrates, carbohydrate and nucleoside chemistry, as well as intermediates, APIs and controlled substances. Customers can partner across the full product life cycle with no need to change suppliers, with manufacturing services from the first idea to the finished product, from route scouting and optimization to GMP or ton-scale production at sites across Europe and Asia. Biosynth’s peptide division, based in the US and Europe, has over 40 years of expertise in assisting pharma and diagnostics customers and specializes in custom peptide synthesis from nmol up to multiKg scale. From peptide discovery and lead optimization, including our own CLIPS™ technology to lock peptides into active conformations, to GMP NCEs and neoantigens to cover all your needs. Biosynth has a synergistic offering of critical biological raw materials, including mono- and polyclonal antibody production and our unique epitope mapping service as a platform to support your antibody development, including patent applications. Biosynth’s enzyme products and solutions are at the forefront of biocatalysis and also include custom enzyme development and production. Through the Biosynth group, we also offer the development of antibodies, antigens, and supply of plasma for in vitro diagnostics. *Biosynth and the Biosynth Group includes the previous and associated brands: Carbosynth, vivitide, New England Peptide, Peptides International, Pepscan, Eucodis Bioscience, Aalto Bio Reagents, Fitzgerald Industries International, Cambridge Research Biochemicals (CRB) & Celares For more information please visit our website: https://www.biosynth.com/

40 Gruberstraße Linz, Oberösterreich, 4020 AustriaVisionaries have shaped this world. It is our vision to develop sensitive analysis methods for application in the early detection of diseases and for biological samples. Our mission derives from this: To create tools to advance research, diagnostics and drug development. That is why we are delving into the molecular level, in order to obtain an even deeper understanding of immunology and cancer biology. We offer our partners and customers answers to their challenges through our expertise and the newest biophysical analysis methods.

Gruberstraße 40-42, 4020 LinzVisionaries have shaped this world. It is our vision to develop sensitive analysis methods for application in the early detection of diseases and for biological samples. Our mission derives from this: To create tools to advance research, diagnostics and drug development. That is why we are delving into the molecular level, in order to obtain an even deeper understanding of immunology and cancer biology. We offer our partners and customers answers to their challenges through our expertise and the newest biophysical analysis methods.

Hauptstraße 5 Maria Enzersdorf, Vienna, 2344 AustriaEstablishment 1994 Founding of CoaChrom Diagnostica GmbH with company headquarters in Vienna, Austria. Company object Development, production and distribution of innovative and high quality reagents for haemostasis diagnostics. Strategic orientation It is our mission to be the most competent, progressive, reliable and not least the friendliest partner in the field of coagulation & fibrinolysis for our customers. For both scientific and practice-oriented questions, we must be able to offer information at any time in the way that you expect from a knowledge-oriented and dynamic company.

Gonzagagasse 16/16, A 1010 Wien, AustriaChiesi farmaceutici offers drug development, drug discovery, and clinical trials.

Vienna, AustriaClinical Investigation Support provides clinical support with a focus on quality assurance.

27 Kreidweg Obsteig, Tirol, 6416 AustriaCyprumed is a drug delivery company with a patent protected platform technology for the oral and nasal delivery of therapeutic peptides and proteins. Cyprumed offers the development of oral and nasal formulations for novel and generic biologics such as peptides and also larger proteins. The delivery technology is entirely based on GRAS excipients. USP and EP monographs are available for all single excipients.

Alserstrasse 23/30 Vienna, Vienna, 1080 AustriaIn-silico based support for pharma to find new therapeutic options for a given indication and discover new indications for a given drug. Delta4 is an AI Drug Discovery TechBio Company that focuses on discovering undetected relationships between drugs with a known safety profile and diseases to identify new indications. Delta4 utilizes Hyper-C (standing for Hyper Connectivity), a platform housing an enormous collection of algorithmic intelligence. It is operated by a team of highly skilled computational biologists that carefully analyze the data to produce unique insights and opportunities. The platform feeds on big data and uses its algorithms and data integration to build molecular models which go through an iterative refinement process matching them to diseases. This sophisticated process utilizing thousands of pre-computed models effectively matches compounds to diseases for more efficient biological testing and clinical trials. What we can do for you: • find new indications for your existing drug • find new drugs in a given indication • identify and rank disease-modifying drug targets • propose prognostic and predictive protein biomarkers • provide specific background info on a drug effect/side effect • generate a strong MoA-hypothesis Several big names in the pharma space (e. g. Top-20 Pharma Company Germany, Top-20 Pharma Company Scandinavia, etc.) have put our high tech platform (Hyper-C) already to the test - with highest satisfaction!

Alserstrasse 23/30 Vienna, Vienna, 1080 AustriaIn-silico based support for pharma to find new therapeutic options for a given indication and discover new indications for a given drug. Delta4 is an AI Drug Discovery TechBio Company that focuses on discovering undetected relationships between drugs with a known safety profile and diseases to identify new indications. Delta4 utilizes Hyper-C (standing for Hyper Connectivity), a platform housing an enormous collection of algorithmic intelligence. It is operated by a team of highly skilled computational biologists that carefully analyze the data to produce unique insights and opportunities. The platform feeds on big data and uses its algorithms and data integration to build molecular models which go through an iterative refinement process matching them to diseases. This sophisticated process utilizing thousands of pre-computed models effectively matches compounds to diseases for more efficient biological testing and clinical trials. What we can do for you: • find new indications for your existing drug • find new drugs in a given indication • identify and rank disease-modifying drug targets • propose prognostic and predictive protein biomarkers • provide specific background info on a drug effect/side effect • generate a strong MoA-hypothesis Several big names in the pharma space (e. g. Top-20 Pharma Company Germany, Top-20 Pharma Company Scandinavia, etc.) have put our high tech platform (Hyper-C) already to the test - with highest satisfaction!

Brehmstarße 14A Vienna, AT-1110 AustriaFAST. We produce and analyse DNA & RNA. Eurofins Genomics is part of the Eurofins Group, with facilities in Europe, the USA and Asia. We are an internationally leading provider of DNA sequencing services, genotyping services, DNA synthesis products and bioinformatics services. COMPLETE. We support you from research to application. With our assistance, you will master any challenge along your value chain. We combine outstanding expertise with state-of-the-art instruments, methods and technologies. We support standard and challenging research projects, as well as complex strategies for large interdisciplinary companies. RELIABLE. We work with academics, pharma, food, diagnostics, agriculture and biotechnology. Our highly automated and lean-optimised lab processes allow us to deliver highly-reliable results. This is documented by the ISO 17025 and ISO 13485 accreditation, as well as the GLP, GCP and cGMP certifications. Reach for the stars. We are glad to assist you!

Shuttleworthstraße 19, A-1210 ViennaFavorgen Biotech Corporation supplies DNA/RNA extraction kits and consumables.

Linz, AustriaFresenius Kabi Product Partnering offers formulation, aseptic filling, quality control, API synthesis and manufacturing services

Estermanstrasse 17 A-4020 Linz AustriaFresenius Kabi Product Partnering offers formulation, aseptic filling, quality control, API synthesis and manufacturing services

7 Schwarzenbergplatz Wien, Wien, 1030 AustriaF-star is a biopharmaceutical company developing novel bispecific antibody products to improve the treatment of cancer.

Breitenfurter Strasse 251 A-1230 Wien AustriaGlobopharm offers development and manufacturing of pharmaceutical products.

21 Pöllau Steiermark, 8311 AustriaAfter working for several years in the chemical industry and as official pesticide consultant I decided to establish an independent agricultural consultancy . Hiebler Agricultural Engineering Services thus came into being as of 1st Jan. 1995. In the first two years the focus was mainly on trials and tests in the fields of fruit and wine farming. Since 1997, a further employee has been working on maize tests. Field trials are carried out on our own sites in Styria (main growing area for fruits and maize in Austria and also a large wine growing area) and additionally on leased sites all over Austria. The large geographic dispersion of the sites allows us to find the most suitable location for the specific pest under investigation at any particular time. For example, trials can be carried out in areas of high precipitation, or in areas exhibiting drier climate conditions, as the need may be.

Horizon Genomics GmbH Campus-Vienna-Biocenter 5 1030 Wien Austria‎Built upon decades of experience engineering cell lines, RNA synthesis, and bioinformatic design, we have created a unique portfolio of reagents and services that empower researchers to push their work forward with data generated from cell models. Horizon is leveraging its technological expertise to provide cell engineering tools and services to its customers in three key areas of the therapeutic ecosystem: basic research, drug discovery and development and therapeutic applications. Some of our central services include: • Screening & Cell line engineering services: tools and services that are designed to improve the outcome of drug discovery and development • BioProduction cell lines: engineered CHO cell lines that are designed to enable efficient biologics manufacturing Horizon’s customers include biopharmaceutical and diagnostics companies, contract research and manufacturing organizations and academic researchers across the globe. Horizon sells its tools and services to more than 2,000 unique customers in over 60 countries, including to 19 of the 20 largest biopharmaceutical companies by revenue. On the contract research front, Horizon’s service group supports researchers with cell line engineering, functional genomic screening, high-throughput immuno-oncology assays, compound profiling, drug combination screening, using CRISPR, or siRNA for a variety of cell-based assays. Horizon is now part of Revvity. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.

Innsbruck, Tyrol AustriaInnovacell Biotechnologie develops personalized cell therapies for treatment of urinary ‎incontinence.

Life Science Center Mitterweg 24 6020 Innsbruck AustriaInnovacell Biotechnologie develops personalized cell therapies for treatment of urinary ‎incontinence.

Clemens Maria Hofbauer-G. 6 A-2344 Maria Enzersdorf Austria, EuropeInte:Ligand offers pharmacore development and modeling, lead structure optimization, virtual compound library generation, and virtual screening services.

Technikerstrasse 21a 6020 Innsbruck AustriaIonicon Analytik provides mass spectrometers and gas detection instruments.

Christoph-Probst-Platz 1, Innrain 52 A - 6020 InnsbruckThe Medical University of Innsbruck stands for outstanding performance in the fields of science, research, teaching and patient care. Together with the university hospital, it is our vision to be the leading centre of medicine in Western Austria. We employ highly qualified teachers to provide our students with the best possible training. The research results of scientists at the Medical University of Innsbruck are published to international acclaim. We aim to further expand our science campus, focus on innovative research in the fields of oncology, neurosciences, immunology and infectiology and further promote scientific exchange between other leading universities in Europe.

Innsbruck Medical University Christoph-Probst-Platz Innrain 52 6020 Innsbruck AustriaWe develop new methods in optical micro-manipulation and in optical microscopy and apply them to biomedical questions. Our specialty is computer-generated holography using so-called “spatial light modulators”. We are interested in various aspects of solar radiation with emphasis on the UV spectral range relevant for humans and the biosphere. We develop spectroradiometric instruments and analysis techniques and measure solar radiation spectra and aerosol optical depth in Innsbruck and during dedicated campaigns. We also operate the Austrian UV measurement network.

Innsbruck, 6020 AustriaWe develop new methods in optical micro-manipulation and in optical microscopy and apply them to biomedical questions. Our specialty is computer-generated holography using so-called “spatial light modulators”. We are interested in various aspects of solar radiation with emphasis on the UV spectral range relevant for humans and the biosphere. We develop spectroradiometric instruments and analysis techniques and measure solar radiation spectra and aerosol optical depth in Innsbruck and during dedicated campaigns. We also operate the Austrian UV measurement network.

Am Campus 1, 3400 Klosterneuburg, AustriaThe Institute of Science and Technology Austria (IST Austria) is a young international institute dedicated to basic research and graduate education in the natural and mathematical sciences, located in Klosterneuburg on the outskirts of Vienna. Established jointly by the federal government of Austria and the provincial government of Lower Austria, the Institute was inaugurated in 2009 and will grow to about 90 research groups by 2026. The governance and management structures of IST Austria guarantee its independence and freedom from political and commercial influences. The Institute is headed by the President, who is appointed by the Board of Trustees and advised by the Scientific Board. The first President of IST Austria is Thomas A. Henzinger, a leading computer scientist and former professor of the University of California at Berkeley and the EPFL Lausanne in Switzerland.

Am Eisernen Tor 3 Graz, 8010 AustriaInnophore, a bioinformatic company, aims to identify and develop high-value industrial and therapeutic enzymes for more efficient, environmentally friendly ‘green’ chemical production processes. Our 3D point-cloud CatalophoreTM technology is also suitable for finding novel biosimilars for medical treatments and contributes to drug repurposing and side-effect prediction.

Plüddemanngasse 39, 8010 Graz, AustriaInnophore, a bioinformatic company, aims to identify and develop high-value industrial and therapeutic enzymes for more efficient, environmentally friendly ‘green’ chemical production processes. Our 3D point-cloud CatalophoreTM technology is also suitable for finding novel biosimilars for medical treatments and contributes to drug repurposing and side-effect prediction.

Plüddemanngasse 39 Graz, 8010 AustriaInnophore, a bioinformatic company, aims to identify and develop high-value industrial and therapeutic enzymes for more efficient, environmentally friendly ‘green’ chemical production processes. Our 3D point-cloud CatalophoreTM technology is also suitable for finding novel biosimilars for medical treatments and contributes to drug repurposing and side-effect prediction.

Altenberger Straße 69, A-4040 Linz, AustriaJohannes Kepler University Linz performs academic research in natural sciences and engineering.

Linz, Upper Austria AustriaJohannes Kepler University (JKU) Linz offers their chemistry and polymer facilities for analysis support.

Haus der Forschung Sensengasse 1 A-1090 Wien, AustriaJOANNEUM RESEARCH is a publicly owned research organisation located in Graz, Austria. Its Institute HEALTH is committed to research in the medical field and health-related disciplines, positioned at the crossroads of technology and medicine. Our clients are mainly pharmaceutical companies (R&D, early development, translational, manufacturing), biotech and medical device companies. To meet industry needs and standards we are certified according to Good Laboratory Practice and EN ISO 13485. Area(s) of expertise 1) Preclinical and clinical studies to investigate local PK, PD profiles in brain, dermal and adipose tissue We carry out ex-vivo and in-vivo studies to investigate the permeation, stability and pharmacokinetics/pharmacodynamics (PK/PD) of active pharmaceutical ingredients under development. OFM studies in live animals with active blood and lymphatic circulation provide important information such as the distinction between permeation and clearance kinetics. The unique capability of OFM technology enables the study of large molecules and immune cells for a better understanding of the mechanism of action (MOA) of the drug candidate under investigation. As a result, the in vivo OFM approach has proven its value in predicting clinical efficacy and supports the right development decisions before entering the clinical phase. ==> https://openflowmicroperfusion.com/ 2) Bioequivalence testing for topical generics: learn more Currently, FDA approval for topical generic drugs requires a clinical endpoint study to show bioequivalence (BE). Standard blood PK studies are not useful for BE tests of topical dermal generics. dOFM allows a PK based BE approach directly in the skin. ==> https://croservices.joanneum.at/ 3) Bioanalysis (under GLP/non-GLP) We analyze low volume samples from all biological matrices to determine PK/PD profiles and to support your biomarker research. We are experts in mass spectrometry and immuno-chemistry and we are dedicated to develop analytical methods for challenging analytes on GLP/GCLP standard, e.g. with ultra-high sensitivity and high sample throughput. ==> https://croservices.joanneum.at/ 4) Pharmaceutical analysis (under GLP/non-GLP) We develop customized solutions for our customers in the pharmaceutical industry in the areas of cleaning validation, content determination and impurity testing. To meet your requirements we combine highly specialized analytics and certified quality standards with know-how from research and development. ==> https://croservices.joanneum.at/ 5) Targeted and untargeted Metabolomics: We are actively developing innovative and optimized analytical methods that can be used to investigate metabolic processes. Toward this end, we pool our bio-analytical, statistical, medical, biological and biochemical expertise and conjoin it with advanced information technology. This strategy allows us to offer a wide range of customer-oriented services in the field of metabolomics and metabolic research. ==> https://croservices.joanneum.at/ 6) Data Management for clinical studies: We provide GCP-compliant comprehensive data management services specifically tailored to your clinical and preclinical studies. We manage data from various sources (e.g. clinical data, laboratory data, medical device data) and provide an easy-to-use, fully validated Electronic Data Capture (EDC) system for your clinical data. We assist with all your data management tasks in a clinical trial, from protocol development to study reporting. ==> https://croservices.joanneum.at/ 7) Biostatistics for clinical studies We offer a wide range of specialized biostatistical services to manage all aspects of your study from design to data analysis. We help you design and power your study to become statistically meaningful and cost-effective. Our profound understanding of clinical trials and our advanced statistical methodology ensures results that are scientifically accurate, validated and reproducible. ==> https://croservices.joanneum.at/ 8) Development of Clinical Decision Support systems We develop and study intelligent software systems to provide safe and evidence-based support for complex clinical processes. We aim to enable professional medical decision-making and adequate patient care by providing modern ICT solutions directly at the point of care.

Neue Stiftingtalstrasse 2 A-8010 Graz, AustriaJOANNEUM RESEARCH is a publicly owned research organisation located in Graz, Austria. Its Institute HEALTH is committed to research in the medical field and health-related disciplines, positioned at the crossroads of technology and medicine. Our clients are mainly pharmaceutical companies (R&D, early development, translational, manufacturing), biotech and medical device companies. To meet industry needs and standards we are certified according to Good Laboratory Practice and EN ISO 13485. Area(s) of expertise 1) Preclinical and clinical studies to investigate local PK, PD profiles in brain, dermal and adipose tissue We carry out ex-vivo and in-vivo studies to investigate the permeation, stability and pharmacokinetics/pharmacodynamics (PK/PD) of active pharmaceutical ingredients under development. OFM studies in live animals with active blood and lymphatic circulation provide important information such as the distinction between permeation and clearance kinetics. The unique capability of OFM technology enables the study of large molecules and immune cells for a better understanding of the mechanism of action (MOA) of the drug candidate under investigation. As a result, the in vivo OFM approach has proven its value in predicting clinical efficacy and supports the right development decisions before entering the clinical phase. ==> https://openflowmicroperfusion.com/ 2) Bioequivalence testing for topical generics: learn more Currently, FDA approval for topical generic drugs requires a clinical endpoint study to show bioequivalence (BE). Standard blood PK studies are not useful for BE tests of topical dermal generics. dOFM allows a PK based BE approach directly in the skin. ==> https://croservices.joanneum.at/ 3) Bioanalysis (under GLP/non-GLP) We analyze low volume samples from all biological matrices to determine PK/PD profiles and to support your biomarker research. We are experts in mass spectrometry and immuno-chemistry and we are dedicated to develop analytical methods for challenging analytes on GLP/GCLP standard, e.g. with ultra-high sensitivity and high sample throughput. ==> https://croservices.joanneum.at/ 4) Pharmaceutical analysis (under GLP/non-GLP) We develop customized solutions for our customers in the pharmaceutical industry in the areas of cleaning validation, content determination and impurity testing. To meet your requirements we combine highly specialized analytics and certified quality standards with know-how from research and development. ==> https://croservices.joanneum.at/ 5) Targeted and untargeted Metabolomics: We are actively developing innovative and optimized analytical methods that can be used to investigate metabolic processes. Toward this end, we pool our bio-analytical, statistical, medical, biological and biochemical expertise and conjoin it with advanced information technology. This strategy allows us to offer a wide range of customer-oriented services in the field of metabolomics and metabolic research. ==> https://croservices.joanneum.at/ 6) Data Management for clinical studies: We provide GCP-compliant comprehensive data management services specifically tailored to your clinical and preclinical studies. We manage data from various sources (e.g. clinical data, laboratory data, medical device data) and provide an easy-to-use, fully validated Electronic Data Capture (EDC) system for your clinical data. We assist with all your data management tasks in a clinical trial, from protocol development to study reporting. ==> https://croservices.joanneum.at/ 7) Biostatistics for clinical studies We offer a wide range of specialized biostatistical services to manage all aspects of your study from design to data analysis. We help you design and power your study to become statistically meaningful and cost-effective. Our profound understanding of clinical trials and our advanced statistical methodology ensures results that are scientifically accurate, validated and reproducible. ==> https://croservices.joanneum.at/ 8) Development of Clinical Decision Support systems We develop and study intelligent software systems to provide safe and evidence-based support for complex clinical processes. We aim to enable professional medical decision-making and adequate patient care by providing modern ICT solutions directly at the point of care.

Leonhardstrasse 59 Graz, Steiermark, 8010 AustriaJOANNEUM RESEARCH is a publicly owned research organisation located in Graz, Austria. Its Institute HEALTH is committed to research in the medical field and health-related disciplines, positioned at the crossroads of technology and medicine. Our clients are mainly pharmaceutical companies (R&D, early development, translational, manufacturing), biotech and medical device companies. To meet industry needs and standards we are certified according to Good Laboratory Practice and EN ISO 13485. Area(s) of expertise 1) Preclinical and clinical studies to investigate local PK, PD profiles in brain, dermal and adipose tissue We carry out ex-vivo and in-vivo studies to investigate the permeation, stability and pharmacokinetics/pharmacodynamics (PK/PD) of active pharmaceutical ingredients under development. OFM studies in live animals with active blood and lymphatic circulation provide important information such as the distinction between permeation and clearance kinetics. The unique capability of OFM technology enables the study of large molecules and immune cells for a better understanding of the mechanism of action (MOA) of the drug candidate under investigation. As a result, the in vivo OFM approach has proven its value in predicting clinical efficacy and supports the right development decisions before entering the clinical phase. ==> https://openflowmicroperfusion.com/ 2) Bioequivalence testing for topical generics: learn more Currently, FDA approval for topical generic drugs requires a clinical endpoint study to show bioequivalence (BE). Standard blood PK studies are not useful for BE tests of topical dermal generics. dOFM allows a PK based BE approach directly in the skin. ==> https://croservices.joanneum.at/ 3) Bioanalysis (under GLP/non-GLP) We analyze low volume samples from all biological matrices to determine PK/PD profiles and to support your biomarker research. We are experts in mass spectrometry and immuno-chemistry and we are dedicated to develop analytical methods for challenging analytes on GLP/GCLP standard, e.g. with ultra-high sensitivity and high sample throughput. ==> https://croservices.joanneum.at/ 4) Pharmaceutical analysis (under GLP/non-GLP) We develop customized solutions for our customers in the pharmaceutical industry in the areas of cleaning validation, content determination and impurity testing. To meet your requirements we combine highly specialized analytics and certified quality standards with know-how from research and development. ==> https://croservices.joanneum.at/ 5) Targeted and untargeted Metabolomics: We are actively developing innovative and optimized analytical methods that can be used to investigate metabolic processes. Toward this end, we pool our bio-analytical, statistical, medical, biological and biochemical expertise and conjoin it with advanced information technology. This strategy allows us to offer a wide range of customer-oriented services in the field of metabolomics and metabolic research. ==> https://croservices.joanneum.at/ 6) Data Management for clinical studies: We provide GCP-compliant comprehensive data management services specifically tailored to your clinical and preclinical studies. We manage data from various sources (e.g. clinical data, laboratory data, medical device data) and provide an easy-to-use, fully validated Electronic Data Capture (EDC) system for your clinical data. We assist with all your data management tasks in a clinical trial, from protocol development to study reporting. ==> https://croservices.joanneum.at/ 7) Biostatistics for clinical studies We offer a wide range of specialized biostatistical services to manage all aspects of your study from design to data analysis. We help you design and power your study to become statistically meaningful and cost-effective. Our profound understanding of clinical trials and our advanced statistical methodology ensures results that are scientifically accurate, validated and reproducible. ==> https://croservices.joanneum.at/ 8) Development of Clinical Decision Support systems We develop and study intelligent software systems to provide safe and evidence-based support for complex clinical processes. We aim to enable professional medical decision-making and adequate patient care by providing modern ICT solutions directly at the point of care.

Nikolaiplatz 4/II Graz, 8020 AustriaWith an extensive background in biomedical imaging, KML Vision has been pushing AI solutions to accelerate image-based research and facilitate decision support in the Life and Health Sciences. With their powerful IKOSA Platform, their goal is to provide a new standard for how AI can be leveraged to advance drug discovery and cancer research.

Industriestraße 12Lifeprint offers plant-DNA analysis, DNA sequence detection, food tests, and assays for genetic modification.

Wienerbergstrasse 11 Vienna Twin Tower A-1100 Wien AustriaLipomed provides reference standards and pharmaceuticals for the treatment of rare diseases.

Am Kanal 27 Vienna Vienna, Austria, 1110 AustriaNext-generation CRISPR screens - a powerful technology to advance drug target identification and validation At Myllia, we utilize the CROP-Seq (for “CRISPR Droplet Sequencing”) workflow to map the impact of thousands of genetic perturbations on the global transcriptome at single-cell resolution, thus effectively establishing a paradigm for next generation CRISPR screens. Our powerful approach has broad applications in identifying novel drug targets, elucidating unknown mechanisms of actions of drugs and understanding genetic variants linked to disease risk. We partner with biotech and pharma companies across the globe, and we perform high-throughput CRISPR screens in cancer cells or primary human T cells on a fee-for-service basis. All CRISPR screens using CRISPR KO, CRISPR interference or CRISPR activation workflows are specifically customized to the needs of our clients and we offer various read-outs (incl. fitness, FACS, flow cytometry, CITE-seq and single-cell transcriptomics) as well as computational biology analysis of NGS data. Finally, we cover end-to-end workflows from initial project design to wet-lab screening and the analysis of NGS data that is fully owned by our clients (no royalties, no strings attached).

5 Campus-Vienna-Biocenter Campus Vienna Biocenter 5 Wien, Wien, 1030 AustriaLexogen develops innovative technologies such as 3’ mRNA-Seq, which have been widely adopted by thousands of scientists worldwide. In addition, we offer end-to-end solutions for RNA analysis and NGS sequencing. Lexogen provides fully customizable NGS Services, which include everything from experimental design to bioinformatics.

Vienna, AustriaThe Medical University of Vienna Biobank is an interface between basic and clinical research with the aim of exploring new diagnostic, prognostic, predictive biomarkers, risk markers and therapeutic strategies to allow, and to deepen the understanding of disease etiology and pathogenesis. As a service center at the Medical University of Vienna sees itself with the principles of ""Good Scientific Practice"" and academia committed. Aware that excellence can be achieved in clinical research only with appropriate ethical standards, the information or consent is subject prerequisite for inclusion in a project of the Medical University of Vienna Biobank. In addition, this also means a responsible use of the provided biological material and the privacy of the subjects involved.

Dr. Bohr-Gasse 9Max F. Perutz Laboratories at the Campus Vienna Biocenter offers its facilities to support research in cell signaling, infection biology, RNA biology, computational biology, and structural biology.

Vienna, Vienna AustriaMax F. Perutz Laboratories at the Campus Vienna Biocenter offers its facilities to support research in cell signaling, infection biology, RNA biology, computational biology, and structural biology.

23 Spitalgasse Wien, Wien, 1090 AustriaThe Core Facility Genomics is a service unit for the characterization of genetic causes of widely-spread diseases by means of high-throughput analyses.

23 Spitalgasse Wien, Wien, 1090 AustriaFlow cytometry has become an essential and widespread resource for the study of biological material.

BioTech Center Muthgasse Muthgasse 11/2 Vienna, 1190 AustriaMycoplasma Biosafety Services GmbH - Driving Innovation in Mycoplasma Detection, Prevention & Control Mycoplasma Biosafety is the global technological and scientific innovation leader in mycoplasma detection, prevention and control. We offer the most comprehensive range of mycoplasma tests by the compendial culture methods and new rapid NAT-based assays, including culture media and reference standard products for mycoplasma testing, test and process validations.

Veterinärplatz 1Mycosafe Diagnostics provides mycoplasma testing, identification, consulting, and validation studies.

23 Spitalgasse Wien, Wien, 1090 AustriaThe Core Facility Imaging is located in the Anna Spiegel Building – Center of Translational Research. In the area of Imaging a large variety of techniques is available to address complex problems in vitro, in situ and in vivo.

Rheinstrasse 49Midas Pharma offers custom manufacturing and synthesis services for API, intermediates, and biologics.

23 Spitalgasse Wien, Wien, 1090 AustriaThe Core Facilities for Genomics, Proteomics, Flow Cytometry and Imaging at the Medical University of Vienna provide scientists with easy access to state-of-the-art high-end equipment and cutting edge technology to address highly sophisticated research questions.

24 Stiftingtalstraße Graz, Steiermark, 8010 AustriaThe Center for Medical Research (ZMF) was established in 2004 to provide first class biomedical research infrastructure for both clinicians and basic research scientists working at the Medical University of Graz. Housed within an imposing, purpose-built modern building located at the heart of the university hospital campus, the ZMF comprises more than 4000 m2 of well-equipped laboratory and office space supporting cutting edge basic and applied biomedical research.

Nova ulica 61Molinspiration Cheminformatics offers virtual in silico screening and structure analysis services.

Leberstrasse 20 Vienna, 1110 AustriaMicrosynth (founded in 1989) is a European leading company in the area of DNA/RNA synthesis & analysis. The main activities are divided into following three business areas: 1. DNA/RNA SYNTHESIS DNA/RNA oligos & probes for R&D Antisense oligos (e.g. 2'-MOE or LNA-gapmers) for drug discovery DNA oligos for diagnostic applications Pilot scale synthesis (gram quantities) 2. DNA/RNA Analysis and Sequencing Sanger sequencing (incl. GMP sequencing) NGS sequencing (16S/ITS, RNA-Seq, etc.) PCR & qPCR & digital PCR Genotyping (GBS, cell lines, fragment analysis) DNA/RNA isolation 3. Contract Research/Outsourcing Assay development (e.g. IVD, liquid biopsy, etc.) Assay validation (e.g. validation of assays according to ICH guidelines) Biological tests (e.g. batch and release tests for drugs) Gene editing/gene therapy (e.g. CRISPR editing analysis, rAAV characterization) At its headquarter in Balgach close to St. Gallen Microsynth employs a staff of about 60 people. Microsynth has subsidiaries in Austria (Microsynth Austria GmbH) and Germany (Seqlab GmbH).

Brunnerstrasse 69 Objekt 3 Vienna, A-1230 AustriaNBS-C BioScience offers assay development for target identification and validation in addition to SPR and ELISA services.

Vienna, Vienna AustriaNBS-C BioScience offers assay development for target identification and validation in addition to SPR and ELISA services.

Stiftingtalstrasse 5 Graz, A-8010 AustriaORIDIS Biomarkers is a specialist in tissue based cancer research and offers expertise in analysis of clinical relevant tissue and biomarker development.

Oberlaaerstrasse 235 Vienna, Vienna, 1100 AustriaOctapharma develops and produces medicines based on human proteins from human cell lines and human plasma, sourced from our own plasma donation centers and other external sources.

Helmut‐Qualtinger Gasse 6, VBC 5 Vienna, 1030 AustriaOpGen is focused on delivering innovative solutions to rapid molecular detection of severe infectious diseases that help guide clinicians with actionable information about life threatening infections to improve patient outcomes and support infection prevention and control and antibiotic stewardship. As part of its genomics offering, ARES isolate sequencing service (ARESiss) is available through the OpGen lab in Rockville, Maryland, USA and the ARES lab in Vienna, Austria. In addition, ARES offers a 16S/ITS amplicon metagenomic sequencing solution (ARESid) for pathogen identification and a culture-free universal pathogenome assay (ARESupa) for comprehensive AMR marker screening of native patient and environmental samples. Sequence characterization supports outbreak analysis, surveillance, and infection prevention and control. To enable labs globally with bioinformatics tools to analyze microbial genomes, OpGen offers AREScloud, a user-friendly web application for AMR surveillance and outbreak analysis, powered by ARESdb. ARESdb is a proprietary AMR reference database comprised of microbial sequences with annotated AMR biomarkers that cover resistance genes and mutations, and it includes matching phenotypic AST data. This enables the AI-powered prediction of phenotypic resistance (predictive AST) directly from genome data.

Entwicklungs GmbH Kahngasse 20 Kahngasse 20 A-8045 Graz A-8045 Graz Austria

Parkring 3 Grambach, 8074 Austria

University of Natural Resources and Applied Life Sciences, Vienna (BOKU)ProGlycAn offers glycan analysis, protein analysis, protein sequencing, and amino acid analysis services.

Donaustraße Klosterneuburg, 3400 AustriaPolymun Scientific offers services in contract development biopharmaceuticals, contract manufacturing biopharmaceuticals, liposomal formulation of drugs and further services.

Donaustrasse 99, 3400 Klosterneuburg, AustriaPolymun Scientific offers services in contract development biopharmaceuticals, contract manufacturing biopharmaceuticals, liposomal formulation of drugs and further services.

99 Donaustraße Klosterneuburg, Niederösterreich, 3400 AustriaPolymun was founded in 1992 by Prof. Hermann Katinger. It is a private company fully owned by the Katinger family. Revenues are generated by contract development and manufacturing as well as creating liposomal formats of drugs for contract partners. These revenues are invested in the proprietary product pipeline and the further development of technology platforms. The R&D projects and technologies are open for co-development and licensing. Polymun operates in accordance with current GMP guidelines and holds an Austrian production license for pharmaceuticals (§63 Austrian Pharmaceutical Law) thus meeting the EU requirements for drug manufacturing. The last inspection by the Austrian regulatory authority AGES on behalf of EMA has taken place in June 2015, the last inspection by FDA in October 2013. COMPETENCE & SERVICES The two core competences of Polymun are the development and manufacture of biopharmaceuticals using mammalian cell technology as well as Polymun's innovative liposome technology and expertise. Today, Polymun can apply this drug delivery platform to all kinds of pharmaceutically active ingredients. The industrial applicability in scale and price is a common focus throughout all projects and technologies.

Industriestrasse 25Sandoz offers API intermediates, peptide and protein synthesis, generic pharmaceutical production, and scale up services.

Biochemiestr. 10Sandoz offers API intermediates, peptide and protein synthesis, generic pharmaceutical production, and scale up services.

Quality Laboratory northeast Hans Czettel Straße 2 A-3950 Gmünd

Parkring 12 Grambach, Austria A-8074Custom-Built Research Services with remarkable flexibility, agility and speed. Contact QPS today! QPS is a global contract research organization (CRO) delivering the highest grade of discovery, preclinical, and clinical drug development services. Since 1995, QPS has rapidly expanded from a tiny bioanalysis shop to a full-service CRO with 1100+ employees in the US, Europe, Asia. Today, it offers expanded pharmaceutical contract Research & Development services with special expertise in Toxicology, DMPK, Bioanalysis, Translational Medicine, as well as Clinical Trials and Clinical Research Services. Through continual enhancements in capacities and resources, QPS stands tall in its commitment to deliver superior quality, skilled performance and trusted service to its valued customers. In 2020, QPS celebrated 25 years in business, adding CLIA-certified and GLP-compliant laboratories ready to provide coronavirus testing assays and support coronavirus vaccine and therapy programs.

13 Inffeldgasse Graz, Steiermark, 8010 AustriaRCPE performs cutting-edge research in the field of process and product optimization. The main focus is on the development of new drug delivery systems and the associated production processes and their monitoring. Application-oriented research and development projects are carried out in collaboration with our industrial and scientific partners. It is our goal to strengthen our partners’ competitive edge and their economic success in the market by helping them develop novel products and production processes. Quality Management RCPE implemented a quality management system in the scope of “Research and Development in Pharmaceutical Science and Pharmaceutical Process Engineering”. In 2015 the company was certified by the TÜV AUSTRIA GmbH according to ISO 9001. The internationally recognized standard demonstrates that all areas of the company focus on quality and customer orientation. 2016 RCPE was certified according to ISO 14001. There the protection of the environment and energy saving usage of resources is the main point.

Dr. Bohr-Gasse 7Research Institute of Molecular Pathology focuses on research in the fields of molecular biology, cellular biology, circuit neuroscience, and diseases.

Vienna, Vienna AustriaResearch Institute of Molecular Pathology focuses on research in the fields of molecular biology, cellular biology, circuit neuroscience, and diseases.

Campus-Vienna-Biocenter 1 Vienna, 1030 AustriaThe Research Institute of Molecular Pathology (IMP) is a leading basic research institute. Its 15 research groups with scientists from 40 countries address fundamental questions in molecular biology. Funded primarily by Boehringer Ingelheim and with unconstrained academic freedom, the IMP is the ideal environment for curiosity-driven biomedical research. As part of the Vienna Biocenter (VBC), the IMP is embedded in one of Europe’s biggest life science hubs with 1400 researchers. Since the IMP’s establishment in 1985, scientists at the institute are addressing important problems in research areas including molecular and cellular biology; structural biology and biochemistry; gene expression and chromosome biology; stem cell biology and development; immunology and cancer; and neuroscience. In pursuit of their research goals, scientists at the IMP employ the latest methods and equipment in molecular genetics, imaging, biochemistry and structural biology on an array of model systems. This is achieved with the help of state-of-the-art core facilities that are available to all research groups free of charge. Research at the IMP is supported by an annual budget of approximately 28 million Euros.

Brehmstrasse 14 Vienna, 1110 AustriaRibbon Biolabs is a synthetic biology company focused on the assembly of complex, highly accurate DNA molecules. By integrating state-of-the-art algorithmics, biochemistry, and adaptive automation with their InfiniSynth® platform, Ribbon Biolabs provides DNA of unmatched accuracy and complexity. Ribbon’s customers can order linear, adapter-free double-stranded DNA up to 12 kb and clonal plasmid DNA up to 20 kb.

Bremstrasse 14 Wein, Vienna, 1100 AustriaRibbon Biolabs is a synthetic biology company focused on the assembly of complex, highly accurate DNA molecules. By integrating state-of-the-art algorithmics, biochemistry, and adaptive automation with their InfiniSynth® platform, Ribbon Biolabs provides DNA of unmatched accuracy and complexity. Ribbon’s customers can order linear, adapter-free double-stranded DNA up to 12 kb and clonal plasmid DNA up to 20 kb.

Boltzmanngasse 11 A-1090 Vienna AustriaSANOCHEMIA offers development and manufacture of novel drugs and diagnostics in; neurodegeneration, pain, oncology and diagnostics based on contrast media.

Gut No.229 - 232,Alandi Markal Road, Village Markal Taluka Khed, Taluka : Khed, Dist : PUNE PIN - 412105 IndiaSewa Medicals manufacture prefillable syringe components and speciality vials.

Tullnerbachstr. 61 - 65 3011 Neupurkersdorf / Austria

Laaer Strasse 7-9Shimadzu offers analytical technology, laboratory instruments, testing machines, and scales.

Schlosshofer Strasse 11, 3. Floor Vienna, A-1210 AustriaThe Siesta Group is a comprehensive service provider supporting the measurement of sleep, wakefulness and brain activity in clinical trials and research. This encompasses, among others, high quality services concerning polysomnography (PSG), pharmaco-electroencephalography (pharmaco-EEG) and event-related potentials (ERP).

Quellenstrasse 110 Wien 10., Favoriten, Wien, 1100 AustriaWe are one of the leading Austrian trade and service partners for medical and laboratory products.Today we distribute and maintain consumables, research products, laboratory instruments and specific diagnostic products. Currently, we can offer a range of more than 1.7 million products and numerous services. Our strength lies in 60 years of experience in the Austrian Life Science Marketplace.

Quellenstrasse 110 Wien, Wien, 1100 AustriaWe are one of the leading Austrian trade and service partners for medical and laboratory products.Today we distribute and maintain consumables, research products, laboratory instruments and specific diagnostic products. Currently, we can offer a range of more than 1.7 million products and numerous services. Our strength lies in 60 years of experience in the Austrian Life Science Marketplace.

Parkring 12 Grambach, 8074 AustriaWe are a Copenhagen based pre-clinical research organization with years of experience in the field of pre-clinical regulatory toxicology. We offer a broad range of services within toxicology, pharmacology, pathology and medical devices. All our staff are highly educated and trained to deliver quality work on time. Whether you are a small biotech company or a large pharma client, you are regarded as a valued partner and we focus on bringing you in contact with our skilled and dedicated scientist as early as possible. We are fully equipped to handle and formulate test items including radioactive labelled compounds as well as controlled substances. Our clinical pathology and histopathology department take care of dose formulation analysis, blood sample analysis as well as production of tissue slides for our skilled pathologists. In our animal facility, housing and care of animals are performed to high standards to ensure optimal health and welfare for all our animals.

Fritz-Atzl-Straße 8 Wörgl, 6300 AustriaSGS helps pharmaceutical, biopharmaceutical, and medical device companies by providing services along the entire drug development pathway. As a global contract research organization, our global Health Science team provides integrated solutions from preclinical activities to Phase I-IV clinical trials, bioanalytical, pharmaceutical development, biologics characterization, biosafety, and quality control testing of small and large molecules, raw materials, containers and finished products. In an ever-changing world, with technological change reaching breakneck speed, SGS helps navigate the sometimes complex process to successfully deliver high quality, safe and medical devices to market. SGS boasts a wealth of global health science expertise. We will support you every step of the way as you deliver first-class, fully compliant biopharmaceutical, pharmaceutical and medical device products. Our expert staff is trained to the highest standards and has an in-depth knowledge of their fields and your business needs.

Brunner Str 67 Vienna, 1230 AustriaTechnoclone offers reagents for diagnostic analysis including plasma, inhibitors, proteins and chromogenic reagents.

2 Sellnergasse Bad Vöslau, Niederösterreich, 2540 AustriaFounded in 1992 by Hermann Koroschetz, TB Agrartechnik today has a staff of seven employees with extensive and well-founded know-how, obtained among others by university degrees in agriculture, biology and biotechnology. Anita Olson, the current managing director, joined the company as a partner in 1994 and has long term and well-founded experience in plant protection and biocidal products. The company is based in Bad Vöslau, a small town situated in one of the most intensively utilised agricultural regions of Austria. TB Agrartechnik also is a testing facility officially recognised by the Austrian Ministry of Agriculture and Forestry in accordance with the Austrian plant protection product law respectively directive 91/414/EEC (93/71/EEC). The results of efficacy testing can additionally be used as a support in the registration of the tested product within the European Community. TB Agrartechnik is specialised in the implementation and handling of the registration of plant protection products, biocidal products and other chemicals.

Trientlgasse 65ThioMatrix provides in vitro/ex vivo studies, formulation development, and preclinical studies.

Innsbruck, Tyrol AustriaThioMatrix provides in vitro/ex vivo studies, formulation development, and preclinical studies.

Brunnerstrasse 67 Vienna, 1140 AustriaTechnoclone Herstellung von Diagnostika und Arzneimitteln GmbH was founded in 1987 by Prof. Dr. Bernd R. Binder. The main focus of the company was on monoclonal antibodies against components of the coagulation and the fibrinolytic systems. Technoclone was worldwide the first company offering a complete set of ELISAs and of a novel patented system allowing determination of activity and antigen in the same sample (Actibind) in the field of fibrinolysis. From 1998 on Technoclone expanded rapidly through the acquisition of the former Immuno diagnostics from Baxter AG and the establishment of an distribution system all over the world. Production and OEM Products Technoclone is a world-leading producer of diagnostics tests, equipments and research products in the area of blood clotting. It offers both global as well as speciality coagulation tests. We see innovation as our duty to help overcome new complexity in the diagnostics of hematological and cardio-vascular disorders. Today more than ever. Technoclone is a world-leading producer of diagnostics tests; equipment’s and research products in the area of blood clotting and offers one of the most complete product portfolios on the market. The Ceveron 100 series is the first fully automated coagulation analyzer series for clotting, chromogenic, turbidimetric assays, thrombin generation and quenching technology (as for FXIII & ADAMTS13 activity). With the development of the new high power LED quenching module the Ceveron s100 is a milestone in speciality haemostasis diagnostics. Technoclone´s high quality in vitro diagnostics and test systems are sold worldwide not only under the Technoclone label but are also found as OEM products in the catalogues of international diagnostics companies. Research & Development The focus of Technoclone´s research and development is in the field of thrombosis and cardiovascular diseases, the world leading cause of mortality and morbidity. Research and development is pursued in Technoclone´s own research division and in close cooperation with Universities and international and national research consortia. Technoclone holds at present more than 10 international patents in the field of diagnosis and therapy of vascular diseases Technoclone, on the forefront of diagnostic challenges of tomorrow.

Brunnerstrasse 67 Vienna, Vienna, 1140 AustriaTechnoclone Herstellung von Diagnostika und Arzneimitteln GmbH was founded in 1987 by Prof. Dr. Bernd R. Binder. The main focus of the company was on monoclonal antibodies against components of the coagulation and the fibrinolytic systems. Technoclone was worldwide the first company offering a complete set of ELISAs and of a novel patented system allowing determination of activity and antigen in the same sample (Actibind) in the field of fibrinolysis. From 1998 on Technoclone expanded rapidly through the acquisition of the former Immuno diagnostics from Baxter AG and the establishment of an distribution system all over the world. Production and OEM Products Technoclone is a world-leading producer of diagnostics tests, equipments and research products in the area of blood clotting. It offers both global as well as speciality coagulation tests. We see innovation as our duty to help overcome new complexity in the diagnostics of hematological and cardio-vascular disorders. Today more than ever. Technoclone is a world-leading producer of diagnostics tests; equipment’s and research products in the area of blood clotting and offers one of the most complete product portfolios on the market. The Ceveron 100 series is the first fully automated coagulation analyzer series for clotting, chromogenic, turbidimetric assays, thrombin generation and quenching technology (as for FXIII & ADAMTS13 activity). With the development of the new high power LED quenching module the Ceveron s100 is a milestone in speciality haemostasis diagnostics. Technoclone´s high quality in vitro diagnostics and test systems are sold worldwide not only under the Technoclone label but are also found as OEM products in the catalogues of international diagnostics companies. Research & Development The focus of Technoclone´s research and development is in the field of thrombosis and cardiovascular diseases, the world leading cause of mortality and morbidity. Research and development is pursued in Technoclone´s own research division and in close cooperation with Universities and international and national research consortia. Technoclone holds at present more than 10 international patents in the field of diagnosis and therapy of vascular diseases Technoclone, on the forefront of diagnostic challenges of tomorrow.

Leberstrasse 20 Vienna, Vienna, 1110 AustriaTAmiRNA is a Viennese Biotech company, which was founded in 2013. TAmiRNA is dedicated to identifying and validating microRNA biomarkers that can be used for drug development, early diagnosis, and prognosis of disease, and as companion diagnostic tests to support treatment decisions. This work requires high-level expertise in working with miRNAs, requiring sophisticated techniques and tools to screen microRNA transcript levels in virtually any type of cell tissue or biological sample. TAmiRNA has a successful track record and impressive pipeline in developing novel miRNA biomarkers for toxicology studies and as predictors of ailments, using these to develop companion diagnostics and monitor disease progression. As a CRO TAmiRNA is able to offer a wide range of validated, high-quality microRNA services, providing specific solutions for: • Transcriptomics: RNASeq, small RNA-Seq, and qPCR analysis of biofluids, cells, tissues, and extracellular vesicles (EVs) to discover and validate multivariate miRNA, non-coding RNA, and messenger RNA biomarkers. • Spatial omics: coupling of laser-assisted microdissection of complex tissues and RNA-seq to decipher gene expression in complex tissues in-situ. • Customer-tailored microRNA biomarker discovery and validation using proprietary small RNA-Seq normalization strategies, machine learning, and customized protocols • Extracellular vesicles, exosomes, nanovesicles: Proteomic, Lipidomic, and Transcriptomic analysis. Characterization of EVs according to the guidelines of the International Society for Extracellular Vesicles. • toxomiR: a microRNA-based screening assay for organ injury in 9 different organ systems, utilizing serum or plasma samples • hepatomiR: a CE-certified assay for the quantification of liver biomarkers (miR-122, miR-192, miR-151a) in human plasma for diagnosis of chronic or acute liver injury.

1 Universitätsring Wien, Wien, 1010 AustriaKnowledge of structure is basic biological research.

Dr. Bohr Gasse 3 1030 Vienna, AustriaThe Vienna Biocenter Core Facilities GmbH (VBCF) is a publicly funded non-profit research institute, situated at the Vienna Biocenter. VBCF was founded in 2010 as a limited liability company (GmbH) according to Austrian law. VBCF’s stakeholders are: Campus Vienna Biocenter Association (50%) Max F. Perutz Laboratories GmbH (25%) IMBA – Institute of Molecular Biotechnology (15%) GMI – Gregor Mendel Institute of Molecular Plant Biology (10%) The operation of VBCF is funded by the Federal Ministry of Science, Research and Economy (bm.wfw) and the City of Vienna, by fees charged for delivered services and by additional research grants. VBCF operates 11 scientific core facilities and the shared Child Care Center of the Vienna Biocenter as shown in the organization chart below.

3 Doktor-Bohr-Gasse Wien, Wien, 1030 AustriaThe Vienna Biocenter Core Facilities GmbH (VBCF) is a publicly funded non-profit research institute, situated at the Vienna Biocenter. VBCF was founded in 2010 as a limited liability company (GmbH) according to Austrian law. VBCF’s stakeholders are: Campus Vienna Biocenter Association (50%) Max F. Perutz Laboratories GmbH (25%) IMBA – Institute of Molecular Biotechnology (15%) GMI – Gregor Mendel Institute of Molecular Plant Biology (10%) The operation of VBCF is funded by the Federal Ministry of Science, Research and Economy (bm.wfw) and the City of Vienna, by fees charged for delivered services and by additional research grants. VBCF operates 11 scientific core facilities and the shared Child Care Center of the Vienna Biocenter as shown in the organization chart below.

Fabrikstraße 3vivo Science offers immunotoxicity services, preclinical studies, REACH testing, and in vivo studies in rodents.

Donau City Strasse 1ViruSure offers virus validation, prion clearance studies, biodistribution, and biosafety testing services.

Brunner Strasse 69 Objekt 3 Wien, Vienna, 1230 AustriaVela Laboratories is a world-wide acting, GLP & GMP-certified, GCLP-compliant accredited contract laboratory. Our services cover analytical services for Biologics (ATMPs, Biopharmaceuticals, Originator products, Biosimilar Candidates, Biosimilars, Blood and blood components, Vaccines), Chemicals and Excipients from early stages of product development (non-clinical, clinical) until market release testing for Pharma and Biotech companies as well as storage facilities enabling long term stability studies and all types of microbiological services. VelaLabs is a member of Tentamus group.

2 Helmut-Qualtinger-Gasse Wien, Wien, 1030 AustriaArsanis is a biotechnology company dedicated to the development of human antibody based therapeutics against severe infectious diseases.

Petersgasse 14, Graz, 8010 AustriaThe Austrian Research Centre of Industrial Biotechnology (ACIB) bundles the expertise of key researchers from 10+ international universities in the multiple disciplines of industrial biotechnology and bioengineering, as well as attracting national and international biotechnological industry and international renowned research institutions as integrated project partners. The centre wants to be the preferred partner for precompetitive research in industrial biotechnology, focused on biocatalysis, bioprocesses, enzymes and (pharmaceutical) protein production. acib’s partners get access to innovative scientific concepts, condensed academic brain power and the broad methodological expertise required in order to develop unique bioprocesses and products. acib’s ambitious research programme includes development of new microbial and mammalian expression systems and concepts, extended innovative applications of biocatalysis, improvement of bioprocesses and understanding bioproduction on a molecular and genome wide basis.

Petersgasse 14, 8010 GrazThe Austrian Research Centre of Industrial Biotechnology (ACIB) bundles the expertise of key researchers from 10+ international universities in the multiple disciplines of industrial biotechnology and bioengineering, as well as attracting national and international biotechnological industry and international renowned research institutions as integrated project partners. The centre wants to be the preferred partner for precompetitive research in industrial biotechnology, focused on biocatalysis, bioprocesses, enzymes and (pharmaceutical) protein production. acib’s partners get access to innovative scientific concepts, condensed academic brain power and the broad methodological expertise required in order to develop unique bioprocesses and products. acib’s ambitious research programme includes development of new microbial and mammalian expression systems and concepts, extended innovative applications of biocatalysis, improvement of bioprocesses and understanding bioproduction on a molecular and genome wide basis.

Golding 501Immune Monitoring Overview Starting with formalin-fixed paraffin embedded tissues, the Immune Monitoring core uses the Vectra Polaris automated slide scanner and NanoString GeoMx Digital Spatial Profiler (DSP) to shed light on the molecular and cellular features of the tumor microenvironment. The Vectra Polaris performs multispectral imaging of 6 markers across 40 slides in a single run. Rapid, unambiguous phenotyping and spatial distribution of immune cells, tumor and stroma can be achieved with minimal hands-on work by the investigator. Spatial RNA sequencing from discrete individual regions of interest comprising a few hundred cells can be accomplished using the GeoMx DSP. This allows the investigator to quantify up to 800 unique transcripts. Services Whole slide scanning with multispectral separation Nanostring nCounter Analyzer GeoMx digital spatial profiler

Austrian Research Centers GmbH - ARC 2444 Seibersdorf, AustriaAustrian Research Centers offers preclinical services, biomarker research, drug discovery support, regulatory consulting, and toxicology.

Zimmermannplatz 10 Vienna, 1090 AustriaSt. Anna Children’s Cancer Research Institute (CCRI) strives to improve treatment for children and adolescents with cancer by bringing together translational and clinical research with open-minded exploration of basic disease mechanisms. ZANDR was established at the Children´s Cancer Research Institute (CCRI) and is a unique platform to phenotypically screen small compounds on zebrafish models of human diseases. Zebrafish and in particular zebrafish larvae is a well suited vertebrate model system to investigate various human diseases and to perform cost-effective screens for small molecules with therapeutic potential. Funded by FFG, we have established a zebrafish-optimized and automated screening platform, which is open to the scientific community.

Am Fischweiher 41-43 Mittenwald, D-82481 GermanyAaron Chemistry specializes in fine chemical and building block synthesis.

Landstrasser Guertel 3 Vienna, 1030 AustriaA creative agency, an internet agency, a pr agency… or straightaway a full-service agency? Definitions are blurring and to be honest – they do not matter anymore. What really matters are unique concepts which guarantee visibility for brands and topics and are put into practice state-of-the-art. Websites, long-term pr guidance, social media campaigns, content management, user experience, SEO, and analytics: all of those services require very specific and versatile know-how – and that’s exactly what asoluto is standing for.

Vienna, Vienna AustriaAssign Group is a fully integrated biotech and pharmaceutical service provider.

Donau City Strasse 6 1220 Wien, AustriaAssign Group is a fully integrated biotech and pharmaceutical service provider.